FindTrial
Sign In

Laboratory Testing

OTHER8 trials

Sponsors

Washington University School of Medicine, Children's Hospital Medical Center, Cincinnati, Oregon Health and Science University, Mayo Clinic, Duke University

Conditions

Ankylosing SpondylitisAtrial FibrillationAxial SpondyloarthopathyAxial SpondyloarthritisBone Marrow DiseaseBreast CancerCardiovascular ComplicationsConcussion

Early Phase 1

Terbinafine Treatment of Axial Spondyloarthropathy
WithdrawnNCT05119712
Oregon Health and Science UniversityAnkylosing Spondylitis, Axial Spondyloarthopathy, Axial Spondyloarthritis +2
Start: 2021-03-09End: 2024-10-15Updated: 2023-08-28

Phase 1

Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1
CompletedNCT00968656
Washington University School of MedicineBreast Cancer, Diffuse Large B-cell Lymphoma, Head and Neck Cancer
Start: 2009-01-31End: 2011-11-30Updated: 2014-12-09
Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)
CompletedNCT00968409
Washington University School of MedicineBreast Cancer
Start: 2007-01-31End: 2011-01-31Updated: 2015-12-09
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
CompletedNCT03793439
Oregon Health and Science UniversitySarcoidosis, Sarcoidosis Lung, Sarcoidosis, Pulmonary
Start: 2019-05-15End: 2021-06-24Updated: 2022-02-18
Pacritinib With Aza for Upfront Myelodysplastic Syndrome
Not yet recruitingNCT07387354
Thomas Jefferson UniversityBone Marrow Disease, Hematologic Diseases, MDS +3
Start: 2026-05-01End: 2027-01-01Target: 25Updated: 2026-03-16

Unknown Phase

Innovative Concussion Prevention Device
CompletedNCT02901028
Children's Hospital Medical Center, CincinnatiConcussion
Start: 2013-04-30End: 2013-08-31Updated: 2016-09-15
A Study to Assess the Use of The Sentinel Device During Atrial Fibrillation Ablation
WithdrawnNCT04683692
Mayo ClinicAtrial Fibrillation
Start: 2023-03-31End: 2024-12-31Updated: 2023-04-14
Cardiac Outcomes With Near-Complete Estrogen Deprivation
RecruitingNCT05309655
Duke UniversityBreast Cancer, Cardiovascular Complications, Triple Negative Breast Cancer
Start: 2022-09-02End: 2028-12-01Target: 90Updated: 2026-03-16

Related Papers

The CROWN study: Cardiac outcomes with near-complete estrogen deprivation.
Journal of Clinical Oncology2024-06-01
Abstract PO3-19-04: The CROWN STUDY: A multicenter prospective cohort study of cardiovascular outcomes in premenopausal women with hormone receptor positive breast cancer treated with ovarian suppression and an aromatase inhibitor
Cancer Research2024-05-02
The CROWN study (CaRdiac outcomes with near complete estrogen deprivation): A multicenter, prospective cohort study of cardiovascular outcomes in premenopausal women with hormone receptor positive breast cancer treated with ovarian suppression and an aromatase inhibitor.
Journal of Clinical Oncology2023-06-01
Ulcerated necrobiosis lipoidica successfully treated with tofacitinib
International Journal of Dermatology2021-11-1616 citations
Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study.
2021-04-0732 citations
Treatment of granuloma annulare with tofacitinib 2% ointment
JAAD Case Reports2019-12-3031 citations